Press Releases Latest May 09, 2024 Theratechnologies Reports on its Annual Meeting of Shareholders Press Releases Year None202420232022202120202019201820172016201520142013 Aug 08, 2019 Theratechnologies Regains Control Over Distribution Rights to Egrifta® Worldwide Aug 07, 2019 Jean-Denis Talon Retires From Theratechnologies’ Board of Directors Aug 05, 2019 Theratechnologies’ Cfo to Attend 39th Annual Growth Conference Held by Canaccord Genuity in Boston Jul 26, 2019 Theratechnologies Receives Positive Recommendation from the CHMP for Trogarzo® in the European Union Jul 11, 2019 Theratechnologies Announces Financial Results for the Second Quarter of 2019 Jun 27, 2019 Theratechnologies to Announce Financial Results for Second Quarter 2019 Jun 20, 2019 Theratechnologies Launches Direct-to-Consumer Campaigns for Trogarzo® and Egrifta® in the United States Jun 17, 2019 Theratechnologies Confirms Decision to Pursue Development of Tesamorelin for NASH in HIV Jun 14, 2019 New Data Released by Theratechnologies Demonstrate Positive Impact of Tesamorelin in Patients with Liver Fibrosis May 24, 2019 European Medicine Agency Grants Theratechnologies an Additional Month to Complete Responses Related to Trogarzo® Application First page « Previous page ‹ … Page 16 Page 17 Page 18 Page 19 Current page 20 Page 21 Page 22 Page 23 Page 24 … Next page › Last page » Displaying 191 - 200 of 362
Aug 05, 2019 Theratechnologies’ Cfo to Attend 39th Annual Growth Conference Held by Canaccord Genuity in Boston
Jul 26, 2019 Theratechnologies Receives Positive Recommendation from the CHMP for Trogarzo® in the European Union
Jun 20, 2019 Theratechnologies Launches Direct-to-Consumer Campaigns for Trogarzo® and Egrifta® in the United States
Jun 17, 2019 Theratechnologies Confirms Decision to Pursue Development of Tesamorelin for NASH in HIV
Jun 14, 2019 New Data Released by Theratechnologies Demonstrate Positive Impact of Tesamorelin in Patients with Liver Fibrosis
May 24, 2019 European Medicine Agency Grants Theratechnologies an Additional Month to Complete Responses Related to Trogarzo® Application